Skip to main content
Erschienen in: Cancer Causes & Control 4-5/2018

01.03.2018 | Original paper

Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer

verfasst von: Erin E. Cook, Susan T. Gershman, Jane J. Kim, Rulla M. Tamimi, R. Monina Klevens, Michelle D. Holmes

Erschienen in: Cancer Causes & Control | Ausgabe 4-5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To understand trends in the incidence and mortality of two human papillomavirus (HPV)-associated cancers, cervical and oropharyngeal cancer, in Massachusetts.

Methods

From 2004 to 2014, the Massachusetts Cancer Registry recorded 3,996 incident cases of oropharyngeal cancer and 2,193 incident cases of cervical cancer. Mortality data were obtained from the Massachusetts Registry of Vital Records and Statistics from 2008 to 2014. Rates were age-standardized to the 2000 U.S. population and trends were assessed using joinpoint regression.

Results

While the incidence rate of cervical cancer (5.46 per 100,000) decreased by 2.41% annually (p = 0.004), the incidence rate of oropharyngeal cancer among males (7.85 per 100,000) increased by 2.82% annually (p = 0.0002). Mortality rates for both cancers decreased from 2008 to 2014 but were not statistically significant (cervical − 3.73% annually, p = 0.29; oropharyngeal − 1.94% annually, p = 0.44).

Conclusion

The rising incidence rate of oropharyngeal cancer in men and the decreasing, but relatively high, incidence rate of cervical cancer in women highlight the need for further screening and prevention by HPV vaccination in Massachusetts.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat U.S. Department of Health and Human Services (DHHS) (2017) National Center for Health Statistics. The 2016 National Immunization Survey—Teen, Hyattsville: Centers for Disease Control and Prevention U.S. Department of Health and Human Services (DHHS) (2017) National Center for Health Statistics. The 2016 National Immunization Survey—Teen, Hyattsville: Centers for Disease Control and Prevention
7.
Zurück zum Zitat Joinpoint Regression, Program, Version 4.4.0.0 - January 2017; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute Joinpoint Regression, Program, Version 4.4.0.0 - January 2017; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute
8.
Zurück zum Zitat SAS 9.3. Cary, NC, USA: SAS Institute Inc SAS 9.3. Cary, NC, USA: SAS Institute Inc
18.
Zurück zum Zitat Herbenick D, Reece M, Schick V et al (2010) Sexual behavior in the United States: results from a national probability sample of men and women ages 14–94. J Sex Med 7(Suppl 5):255–265CrossRefPubMed Herbenick D, Reece M, Schick V et al (2010) Sexual behavior in the United States: results from a national probability sample of men and women ages 14–94. J Sex Med 7(Suppl 5):255–265CrossRefPubMed
21.
Zurück zum Zitat Addison D, Seidelmann SB, Jangua SA et al (2017) Human papillomavirus status and the risk of cerebrovascular events following radiation therapy for head and neck cancer. J Am Heart Assoc 6(9):e006453CrossRefPubMedPubMedCentral Addison D, Seidelmann SB, Jangua SA et al (2017) Human papillomavirus status and the risk of cerebrovascular events following radiation therapy for head and neck cancer. J Am Heart Assoc 6(9):e006453CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Lorch JH, Hanna GJ, Posner MR et al (2015) Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: the Dana Farber experience. Head Neck 38(S1):E1618–E1624 Lorch JH, Hanna GJ, Posner MR et al (2015) Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: the Dana Farber experience. Head Neck 38(S1):E1618–E1624
23.
Zurück zum Zitat Nelson HH, Pawlita M, Michaud DS et al (2017) Immune response to HPV16 E6 and E7 proteins and patient outcomes in head and neck cancer. JAMA Oncol 3(2):178–185CrossRef Nelson HH, Pawlita M, Michaud DS et al (2017) Immune response to HPV16 E6 and E7 proteins and patient outcomes in head and neck cancer. JAMA Oncol 3(2):178–185CrossRef
24.
Zurück zum Zitat Nichols AC, Finkelstein DM, Faquin WC et al (2010) Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Can Res 16(7):2138–2146CrossRef Nichols AC, Finkelstein DM, Faquin WC et al (2010) Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Can Res 16(7):2138–2146CrossRef
25.
Zurück zum Zitat Ringstrom E, Peters E, Hasegawa M et al (2002) Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8(10):3187–3192PubMed Ringstrom E, Peters E, Hasegawa M et al (2002) Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8(10):3187–3192PubMed
26.
Zurück zum Zitat Stang A, Hawk H, Knowlton RK et al (2014) Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010. Ann Epidemiol 24(11):849–854CrossRefPubMed Stang A, Hawk H, Knowlton RK et al (2014) Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010. Ann Epidemiol 24(11):849–854CrossRefPubMed
28.
Zurück zum Zitat Wagner R, Villa A (2107) Oral human papillomavirus infections and the role of the dental professional. J Massachusetts Dent Soc 65(4):12–15 Wagner R, Villa A (2107) Oral human papillomavirus infections and the role of the dental professional. J Massachusetts Dent Soc 65(4):12–15
Metadaten
Titel
Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer
verfasst von
Erin E. Cook
Susan T. Gershman
Jane J. Kim
Rulla M. Tamimi
R. Monina Klevens
Michelle D. Holmes
Publikationsdatum
01.03.2018
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 4-5/2018
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1016-1

Weitere Artikel der Ausgabe 4-5/2018

Cancer Causes & Control 4-5/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.